Exane Derivatives Exact Sciences Corp Call Options Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EXAS
# of Institutions
672Shares Held
163MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.1 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$983 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$890 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$749 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$415 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...